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Abstract
Streptococcus pyogenes is a leading cause of pharyngeal infection, with an estimated 616 million cases per year. The human
nasopharynx represents the major reservoir for all S. pyogenes infection, including severe invasive disease. To investigate
bacterial and host factors that influence S. pyogenes infection, we have devised an improved murine model of
nasopharyngeal colonization, with an optimized dosing volume to avoid fulminant infections and a sensitive host strain. In
addition we have utilized a refined technique for longitudinal monitoring of bacterial burden that is non-invasive thereby
reducing the numbers of animals required. The model was used to demonstrate that the two component regulatory system,
CovR/S, is required for optimum infection and transmission from the nasopharynx. There is a fitness cost conferred by covR/
S mutation that is specific to the nasopharynx. This may explain why S. pyogenes with altered covR/S have not become
prevalent in community infections despite possessing a selective advantage in invasive infection.
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Introduction
Streptococcus pyogenes is estimated to cause 616 million cases of
pharyngeal infection per year, and 663,000 cases of invasive
disease [1]. As the human nasopharynx represents the major
reservoir for all types of S. pyogenes infection, it is essential to
develop a better understanding of the factors that influence upper
respiratory tract infection.
Despite their limitations, mice play an important role in
infectious diseases research [2]. The mouse nasopharynx has
structural similarities to the nasal turbinate system in humans [3],
although mice lack tonsils [4]. Instead, mice possess nasal
associated lymphoid tissue (NALT), which shares some similarity
to the tonsils [5] and has been shown to be a target for infection by
S. pyogenes [6]. Indeed, mice have been used by several groups to
investigate S. pyogenes in the upper respiratory tract, although there
is no consensus on which is the most appropriate strain, sex or age
of animal to use [6,7,8,9,10]. Furthermore, the maximum dose
volume posited for establishing infection by previous studies ranges
from 5 ml, as determined by administration of colored dye [8,11],
10 ml as determined by radioactive microspheres [10,12], to 20 ml
volumes [6]. This is an important consideration, as aspiration of
the bacteria into the lungs has the potential to trigger a more
invasive disease and systemic infection.
It is known that phenotypic differences can exist between
nasopharyngeal and invasive S. pyogenes isolates, and these have
been ascribed to altered activity or mutation of the streptococcal
two component regulatory system, covR/S [13]. As a result of
signalling from the sensor kinase, CovS, CovR represses a range of
virulence factors concerned with resistance to phagocytosis, such
as the capsule synthesis operon hasABC, the DNase, sda, and the
CXC chemokine protease, SpyCEP [13,14,15,16,17]. Mutations
in covR/S de-repress these virulence genes, conferring a selective
advantage to S. pyogenes in mouse models of invasive infection,
leading to greater mortality [15,18]. However, the impact of such
mutations on nasopharyngeal infection is unclear. Isolates of S.
pyogenes with covS mutations bind less well to skin cells in vitro and
in vivo than those without the mutation [19]. Furthermore, S.
pyogenes with mutations in covS lack competitiveness in the saliva
relative to wild type [20].
In this work, we set out to produce a longitudinally monitored
murine model of nasopharyngeal infection, by examining the
effect of mouse strain, age and sex on S. pyogenes carriage. We
evaluated S. pyogenes pharyngitis isolates from patients rather than
a previously-described mouse-pathogenic strain that lacks a func-
tional copy of the multigene activator, mga [21,22]. The improved
nasopharyngeal infection model was used to evaluate the impact of
the S. pyogenes CovR/S two component regulatory system on




In vivo experiments were performed in accordance with the
Animals (scientific Procedures) Act 1986, subject to protocols set
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out in PPL 70/7379 that were approved by the Imperial College
Ethical Review Process (ERP) panel and the UK Home Office.
Bacterial Strains
The bacterial strains used in this study are given in Table 1
[16,23,24]. Streptococcal strains were cultured in Todd Hewitt
Yeast broth (THY) or on Columbia Blood Agar (CBA), while
Luria Bertani (LB) medium was used for culturing C. rodentium
ICC180. All strains were grown at 37uC. For animal experiments,
S. pyogenes was grown without shaking with 5% CO2 overnight,
centrifuged at 18646g, (Sorvall RTH 750 Rotor), washed twice in
phosphate buffered saline (PBS), and re-suspended in PBS to
produce an inoculum of 1–76108 colony forming units (cfu) per
5 ml. Numbers of viable bacteria within the inoculum were
retrospectively assessed by plating of 1026–1028 dilutions of the
inoculum onto agar.
Animals
Male and female 5–10 week old CD1, C57BL/6, A/J, BALB/c,
FVB/n specific-pathogen free mice (Harlan, UK) were maintained
in individually HEPA filtered cages with sterile bedding and free
access to sterilized food and water. GLP Mini Fun Tunnels
(Lillico), or Des. Res. Mini Mouse Houses (Lillico) were provided
in each cage for environmental enrichment.
Intranasal Infection
Pilot experiments were conducted using ,109 cfu in doses of
2.5 ml–20 ml bioluminescent C. rodentium ICC180 [24] to de-
termine the correct dosing strategy to deliver bacteria to the
murine nasopharynx without lung involvement. Bioluminescence
(as photons s21 cm22 steridian [sr] 21) from living animals was
performed as previously described [24] using an IVISH 100 system
(Perkin Elmer).
For streptococcal infection of the nasopharynx, 1–76108 cfu of
S. pyogenes was administered intranasally using a pipette to mice in
a volume of 2.5 ml per nostril under 2–5% isoflurane anaesthesia.
Mice were weighed daily; reduction by 20% of original weight was
a defined humane endpoint.
Intramuscular Infection
66108 cfu S. pyogenes were administered to mice under isoflurane
anaesthesia via injection with a 27 gauge needle into the right
lateral thigh. Numbers of viable bacteria within the inoculum were
assessed by retrospective plating of 1026–1028 dilutions. At 72
hours, the right thigh muscle and ipsilateral inguinal node were
extracted, weighed and homogenized into PBS and then plated
out onto CBA for bacterial enumeration.
Table 1. Bacterial strains used in this study.
Strain Designation Emm type Species Description Ref.
H305 emm1 S. pyogenes Scarlet fever reference strain [23]
H343 emm2 S. pyogenes Pharyngitis isolate [16]
H292 emm81 S. pyogenes Blood isolate [16]
H347 emm75 S. pyogenes Pharyngitis isolate [16]
H494 emm75 S. pyogenes Strain H347 with an inactivated covR/S operon [16]
ICC180 C. rodentium Bioluminescent derivative of ICC169 [24]
doi:10.1371/journal.pone.0061655.t001
Figure 1. Bioluminescence imaging of bacterial distribution after intranasal inoculation with bioluminescent C. rodentium. 109 colony
forming units (cfu) of bioluminescent C. rodentium were administered intranasally to 8 week old CD1 outbred female mice in 20 ml (n = 3), 10 ml
(n = 2), 5 ml (n = 3) and 2.5 ml (n = 2) of PBS. Images were acquired using an IVIS spectrum system, and are displayed as images of peak
bioluminescence, with variations in colour representing light intensity at a given location. Red represents the most intense light emission, while blue
corresponds to the weakest signal. The colour bar indicates relative signal intensity (as photons s21 cm2 sr21). Two representative mice shown for
each group.
doi:10.1371/journal.pone.0061655.g001
S. pyogenes in the Nasopharynx
PLOS ONE | www.plosone.org 2 April 2013 | Volume 8 | Issue 4 | e61655
Nasal Sampling
The level of shedding of S. pyogenes from the nasopharynx was
assessed longitudinally using direct nasal sampling. The nares of
each mouse were gently pressed onto the surface of a CBA plate
ten times. Exhaled particulates were streaked out, and the plates
were then incubated overnight at 37uC with 5% CO2 for bacterial
enumeration. In preliminary experiments using naive, non-
infected mice, a-hemolytic streptococci, staphylococci, pseudomo-
nads and corynebacteria were recovered, but no b hemolytic
Group A streptococci were found to naturally colonize the mouse
nasopharyngeal tract.
For experiments where mice had been infected with S. pyogenes,
b-hemolytic colonies were counted for each mouse and confirmed
as S. pyogenes through Gram staining, catalase testing, oxidase
testing, and Lancefield grouping. No other b-haemolytic bacteria
were recovered from the mouse nasopharynx. Kaplan-Meier plots
were created to analyse the duration of S. pyogenes shedding. Nasal
samples were taken for 21 days post inoculation. Mice were
determined to have stopped shedding upon the first instance of
a nasal sample turning up negative.
In some studies, the nasopharynx was dissected and removed at
fixed time points for microbiological culture. To ensure complete
extraction of the nasopharynx, the skin and mandibles were
removed to expose the cranium. This was then sectioned along the
coronal plane at the bregma. The brain tissue within the cranium
anterior to this incision was removed, exposing the posterior aspect
of the nasal cavity, known as the cribriform plate. The orbits were
removed from this tissue via sagittal incisions lateral to the pre-
maxilla. The remaining tissue comprised the entire nasal cavity,
and NALT. This was homogenized into PBS and serial dilutions
plated onto CBA to quantify S. pyogenes from the whole
nasopharynx.
Settle Plates
To detect the presence of airborne bacteria within cages of
infected mice, CBA plates were placed in the upper rack of the
individually HEPA filtered cages (n = 4 plates per cage) and
exposed for defined time periods throughout each experiment.
Plates then incubated overnight at 37uC and the numbers of S.
pyogenes colonies, (identified by Gram staining, catalase testing, and
Lancefield grouping) were enumerated.
Histopathology
The head of each mouse was removed at the atlanto-occipital
joint and sagittally hemi-sected. One half was fixed in formalin
and processed routinely to paraffin wax, while the other was
homogenised and plated to assess S. pyogenes numbers in the
nasopharynx. Paraffin sections were cut at 6 mm and stained
with Haematoxylin and Eosin and Gram stains. The degree of
nasal damage and inflammation was scored as : No significant
abnormality (Intact nasal mucosa and absence of inflammation),
Mild (Focal erosion of the mucosa with local neutrophil
exocytosis across the affected epithelium), Moderate (Focal
necrosis and ulceration of the mucosa with local neutrophilic
exocytosis and surface neutrophilic exudation), Marked (Exten-
sive necrosis and ulceration of the mucosa with widespread
neutrophilic exocytosis and surface neutrophilic exudation) and
Severe (Extensive necrosis and ulceration of the mucosa with
widespread neutrophilic exocytosis and surface neutrophilic
exudation and with extension of necrosis into underlying
stroma). Slides were reviewed and scored by an experienced
histopathologist (KS).
Statistics
For statistical analysis of Kaplan-Meier curves, the Mantel-
Cox Logrank test was applied. For statistical analysis of colony
count comparisons, a non-parametric Kruskal-Wallis test and
Dunn’s post-test were used. P values less than 0.05 were defined
as significant. Statistics were performed using Prism Graphpad
version 5.02. Data are presented as median, 6 interquartile
range.
Results
Volume of Inoculum Determines Distribution within the
Respiratory Tract
Bioluminescence imaging demonstrated that dose volumes of
20 ml volume delivered bacteria to the lungs, whereas this was
not shown with lower volumes (Figure 1). Any dose volume
above 10 ml was deposited in the trachea. Dose volumes of 5 ml
and 2 ml did not distribute bacteria to the lungs. As the optimal
dose volume for nasopharyngeal deposition without lung
involvement or significant nasal clearance was 5 ml (2.5 ml per
nostril), this was the volume used in subsequent experiments.
Figure 2. Correlation between S. pyogenes recovered from nasal
shedding and from nasopharyngeal dissection. Data are pooled
from direct nasal samples taken on days 3, 7, and 14 from five week old
female FVB/n mice during intranasal infection with emm75 S. pyogenes
(1.36108 cfu) were compared to bacterial numbers obtained on
dissection on the same days. (r2.0.95, n = 36). Data shown from
individual mice.
doi:10.1371/journal.pone.0061655.g002
Table 2. Duration of shedding of different strains of S.
pyogenes (76108 cfu per 5 ml dose) in 8 week old male BALB/c
mice after intranasal infection.
Number of mice shedding S. pyogenes
Day 1 Day 2 Day 3
emm1 0/7 0/7 0/7
emm2 1/7 1/7 1/7
emm75 4/7 3/7 2/7
emm81 1/7 0/7 0/7
doi:10.1371/journal.pone.0061655.t002
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Nasopharyngeal Shedding as a Method to Longitudinally
Monitor S. pyogenes Infection in the Upper Respiratory
Tract
To select an appropriate bacterial strain for development of the
model, BALB/c mice were intranasally inoculated with four
clinical S. pyogenes strains of different emm genotypes. An emm75
pharyngitis strain was found to have shed for the longest period
using direct nasal sampling (Table 2) and was used in subsequent
experiments. Importantly, a significant correlation was found
between the numbers of colonies recovered from nasal shedding of
S. pyogenes and bacterial numbers from dissected and homogenised
nasal tissue on the same day (Figure 2, r2.0.95, n = 36). This
longitudinal method of monitoring was therefore employed in
subsequent experiments consistent with the principles of the 3Rs
(Replacement, Refinement, and Reduction) by reducing the
numbers of animals used.
Longevity of Nasopharyngeal Shedding is Greater in FVB/
n Mice
To determine the most appropriate mouse strain for model
development, male mice of different host backgrounds were
infected intranasally with emm75 S. pyogenes, and observed
longitudinally for 72 h using direct nasal sampling. Data were
used to create Kaplan Meier plots to analyse the duration of
shedding for each strain of mouse (Figure 3 A). FVB/n mice
carried S. pyogenes longer and shed significantly more S. pyogenes on
the final day of the time course than all other strains tested
Figure 3. Comparison of nasopharyngeal shedding of S. pyogenes between different mouse strains. Five week old male mice of different
strain backgrounds were inoculated intranasally with emm75 S. pyogenes (1.56108 cfu). Duration and quantity of shedding were determined from
colonies recovered from direct nasal sampling of the mouse nasopharynx. (A) Kaplan-Meier plot showing percentage of mice shedding S. pyogenes in
each group. (B) Bacterial counts shed by FVB/n (n = 8) CD1 (n = 14), BALB/c (n = 14), C57BL/6 (n = 12) and A/J (n = 6) at 72 hours. Individual points
represent individual mice. (Kruskal Wallis with Dunns Post Test p,0.05). Bars indicate the median, ND = no detectable bacteria.
doi:10.1371/journal.pone.0061655.g003
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(Figure 3 B). FVB/n mice carried S. pyogenes were therefore used
for all future studies.
Gender has an Effect on the Nasopharyngeal Carriage of
S. pyogenes that is Dependent on the Age of the Mice
To determine whether gender influenced S. pyogenes infection of
the nasopharynx, peri pubertal (n = 10 per group, 5 per cage, 5
Figure 4. Sex differences in S. pyogenes nasopharyngeal carriage and shedding intensity in 5 week old mice. Male and female FVB/n
mice 5 weeks (A, p.0.05 Mantel–Cox Logrank test, n = 10) of age were infected intranasally with emm75 S. pyogenes (1.16108 cfu) and sampled non-
invasively through direct nasal sampling over 21 days. Shedding intensity maps display the data from direct nasal samples throughout the time
course from the male mice (B) and the female mice (C). Rows indicate individual mice throughout the time course, colours indicate the numbers of S.
pyogenes recovered from direct nasal samples with red indicating the highest recorded levels of carriage ($5000 cfu) and green indicates the lowest
levels of carriage (1 cfu) and blank blocks indicate no recovery of S. pyogenes. Black line indicates survival based on the first loss of carriage.
doi:10.1371/journal.pone.0061655.g004
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Figure 5. Sex differences in S. pyogenes nasopharyngeal carriage and shedding intensity in 10 week old mice. Male and female FVB/n
10 weeks (A, p,0.05 Mantel–Cox Logrank test, n = 10) of age were infected intranasally with emm75 S. pyogenes (1.16108 cfu) and sampled non-
invasively through direct nasal sampling over 21 days. Male mice carried S. pyogenes for significantly longer than the female mice in this age group.
Shedding intensity maps display the data from direct nasal samples throughout the time course from the male mice (B) and the female mice (C).
Rows indicate individual mice throughout the time course, colours indicate the numbers of S. pyogenes recovered from direct nasal samples with red
indicating the highest recorded levels of carriage ($5000 cfu) and green indicates the lowest levels of carriage (1 cfu) and blank blocks indicate no
recovery of S. pyogenes. Black line indicates survival based on the first loss of carriage.
doi:10.1371/journal.pone.0061655.g005
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weeks of age) and post pubertal (n = 10 per group, 5 per cage, 10
weeks of age) male and female FVB/n mice were intranasally
inoculated with S. pyogenes. There was no significant difference in
infection duration between 5 week old males and females over a 21
day period (Figure 4, Logrank p.0.05), whereas 10 week old males
shed S. pyogenes for significantly longer than 10 week old female
mice (Figure 5, Logrank test p,0.05). However, the older males
had to be housed separately to prevent intraspecific aggression and
for this reason further experiments were conducted using female
mice.
Figure 6. Nasopharyngeal infection is adversely affected by covR/Smutation. Five week old female FVB/n mice were inoculated intranasally
with either emm75 S. pyogenes, or DcovR/S S. pyogenes. To determine the duration of shedding, direct nasal samples were taken over a 21 day period.
The wild type strain was shed over a significantly longer time period than the DcovR/S strain (A, 1.56108 cfu per dose, n = 20 per group, Logrank
Mantel Cox p,0.05). Shedding intensity maps display the data from direct nasal samples throughout the time course from the groups infected with
the wild type emm75 strain (B) and the mice infected with the DcovR/S strain (C). Rows indicate individual mice throughout the time course, colours
indicate the numbers of S. pyogenes recovered from direct nasal samples with red indicating the highest recorded levels of carriage ($5000 cfu) and
green indicates the lowest levels of carriage (1 cfu) and blank blocks indicate no recovery of S. pyogenes. Black line indicates survival based on the first
loss of carriage.
doi:10.1371/journal.pone.0061655.g006
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DcovR/S Mutation is Detrimental to Long Term S.
pyogenes Infection of the Nasopharynx
Two groups of FVB/n female mice (n = 20, 5 per cage) were
infected intranasally with 5 ml of 108 cfu of emm75 S. pyogenes or an
isogenic DcovR/S strain and observed over 21 days. Kaplan Meier
analysis of daily nasal samples demonstrated that the DcovR/S
strain was shed from the nasopharynx for a shorter length of time
compared to its wild type counterpart. (Figure 6, Mantel Cox
Logrank p,0.05).
We considered the possibility that the reduced longevity of
infection reflected a general fitness defect in the DcovR/S strain.
However, following intramuscular infection of groups of mice with
each strain, both the DcovR/S strain and wild-type strain survived
equally well within the thigh muscle (n = 12 per group, 6 per cage,
Figure 7 A). Furthermore the DcovR/S strain disseminated to the
ipsilateral inguinal lymph node in greater numbers than the wild-
type (Figure 7 B, p,0.05 Mann-Whitney), consistent with the
predicted phenotype of a DcovR/S strain. Streptococci were
detected in the liver (Figure 7 C) and in the spleen (Figure 7 D),
but these differences were not significant.
Intranasal Administration of S. pyogenes Results in
a Suppurative Upper Respiratory Tract Infection that
Resolves Over 21 Days
5 week old female FVB/n mice infected with emm75 S. pyogenes
demonstrated inflammatory changes affecting the nasal cavity over
the first week of infection (Figure 8, A–D), particularly in the
caudal (ethmoturbinate) region. A moderate to marked suppura-
tive rhinitis with complete erosion or ulceration of the nasal
mucosa and neutrophilic exudate on the mucosal surface was
observed. On days 3 and 7, mice occasionally demonstrated
necrosis of underlying turbinate bone and extension of in-
flammation and infection across the cribriform plate, resulting in
a localized meningoencephalitis affecting the olfactory bulbs (data
not shown). However, by Day 21, the inflammatory damage to the
nasal mucosa had resolved. The S. pyogenes DcovR/S strain elicited
a similar inflammatory response (Figure 8, E–H), albeit over
a slightly shorter time period. Mice demonstrated mild to marked
suppurative rhinitis at days 3 and 7 that resolved by day 14. Both
strains of S. pyogenes could be recovered from cultures of the
nasopharynx from mice even after the inflammation resolved
(Data not shown). Semi quantitative assessment of sections from
mice infected with both the wild type and DcovR/S emm75 strains
were undertaken in comparison with control sections from
uninfected mice; this demonstrated that the observed inflamma-
Figure 7. The effects of covR/S mutation on dissemination from an invasive intramuscular infection. Five week old FVB/n female mice
(n = 12) were infected intramuscularly in the right thigh with either wild type S. pyogenes or an isogenic DcovR/S strain (66108 cfu per dose). After
three days there was no significant difference in bacterial growth within the thigh (A, Mann Whitney U p.0.05), but there was a significant difference
in bacterial numbers that had disseminated to the inguinal node (B, Mann Whitney U p,0.05). No significant difference in dissemination to the liver
(C) and the spleen (D) was found between the wild type and the DcovR/S strains. Median indicated by a black line.
doi:10.1371/journal.pone.0061655.g007
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Figure 8. Histopathological analysis of the caudal nasal cavity during long term nasal infection. Photomicrographs demonstrating five
week old female FVB/n mice infected with either the emm75 S. pyogenes (A–D) or the emm75 DcovR/S strain (E–H) (1.56108 cfu per dose, n = 3 per
group) were taken at days 3, 7, 14 and 21 after inoculation (Haemotoxylin & Eosin staining). n= Neutrophilic Exudate, m= Nasal mucosa, s= Nasal
stroma. Scale bar as shown. Damage to the nasal mucosa with surface neutrophilic exudate was apparent at day 3 post inoculation with both strains
(A & E). The nasal epithelia of mice in both groups were widely eroded or ulcerated by day 7 (B) than those infected with the DcovR/S strain (F). At day
14 the inflammation had begun to resolve in both strains (C & G). By day 21, mice in all groups had histologically normal mucosa (D & H). Control
mice over the time course are shown in (I–L). Semi quantitative analysis of the histopathology was undertaken to determine the severity of infection
and assigned a numerical designation for each time point (n = 3 mice per time point). 2= No significant abnormality,+= Mild,++= Moder-
ate,+++= Marked,++++= Severe and ND = Non diagnostic sections (M).
doi:10.1371/journal.pone.0061655.g008
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tion decreased throughout the time course consistent with the
lowering of the bacterial load (Figure 8 I–M).
Transmission of S. pyogenes within a Mouse Cage is
Dependent on the Proportion of Infected Donor Mice
Present
Preliminary work showed that S. pyogenes shed by infected mice
could lead to the infection of uninfected mice in the same cage.
Transmissibility of S. pyogenes in the nasopharynx was formally
investigated through introducing infected donor mice into cages of
uninfected recipient mice (n = 8 per cage). The effect of varying
the ratio of donor to recipient (D:R) mice present in a cage on
transmission was evaluated.
Within 4 hours of donor introduction transmission occurred to
all recipients. A higher D:R ratio resulted in greater counts of S.
pyogenes cultured from recipient mice in those cages. Recipient
mice in the cage with a D:R ratio of 4:4 had significantly more
bacteria in the nasopharynx compared to mice in the cage with
a D:R ratio of 2:6 (Figure 9 p,0.05).
DcovR/S Mutation is Detrimental to the Transmission of S.
pyogenes in a Mouse Model
Mice were observed over the first three days of infection, when
shedding of the wild-type and the DcovR/S strain were shown to be
similar, to determine whether a mutation in covR/S affects
transmission.
Female FVB/n mice infected with either the wild-type or the
DcovR/S strains were introduced into cages at a D:R ratio of 3:5.
After inoculation, the infected mice were separated for six hours
before being introduced to the recipients, to prevent passive
inoculum transfer. Direct nasal samples were taken from recipient
mice over three days after the introduction of the donor mice.
Recipient mice housed with donor mice carrying wild type S.
pyogenes acquired significantly more bacteria over the time course
than the recipient mice housed with donor mice carrying the
DcovR/S strain (Figure 10 A, AUC analysis, with Mann Whitney U
p,0.05).
There was no statistically significant difference in the abun-
dance of airborne S. pyogenes in the cages of mice infected with the
wild-type compared with the cages of mice infected with the
DcovR/S strain. (Figure 10 B, AUC analysis with Mann Whitney U
p.0.05).
Discussion
To facilitate the investigation of bacterial and host factors that
influence S. pyogenes in nasopharyngeal infection, an improved, new
model of nasopharyngeal colonisation was devised, with an
optimised dosing volume to avoid fulminant infections. A non-
invasive method of longitudinal monitoring was developed that
does not require culling of mice at multiple time points, thus
reducing the numbers of animals used.
An emm75 strain of S. pyogenes was found in preliminary
experiments to be carried better than other emm types by
BALB/c mice, although previous studies have however found
that the BALB/c strain is more resistant to infection than other
strains [9]. A number of mouse strains were therefore tested in this
study, of which the FVB/n was found to be the most susceptible to
S. pyogenes intranasal infection. Emm types 1, 2, 3, 4, 6, 12, 22 and
89 were also successfully carried by FVB/n mice (data not shown),
although in some cases causing a far more severe disease than the
emm75 strain, making them unsuitable for long term infection
studies.
We found that gender had an impact on susceptibility to
carriage in post pubertal mice only. Data were consistent with
other published work demonstrating an increase in susceptibility to
infection in male mice [9,25]. However, the intraspecific
aggression expressed by males of this strain made them difficult
to house in groups, and thus the older individuals were housed
individually. In previous studies, housing mice singly has been
demonstrated to increase immune responses [26,27,28], and
would theoretically increase their resistance to infection.
Histological analysis during infection revealed that nasal
shedding of S. pyogenes was associated with on-going inflammation
that subsided in the second and third weeks of infection. Previous
studies have demonstrated bacterial infection of the mouse NALT
[6]. However this study focussed on the site of infection in the
deeper nasal passages, which demonstrated a suppurative rhinitis.
Studies have shown that S. pyogenes distributes to the ethmoid
sinuses in humans during rhinosinusitis [29,30].
The model was used to demonstrate that a functional covR/S is
required for optimum infection and transmission from the
nasopharynx. The failure of the DcovR/S strain to survive in the
mouse nasopharynx was not due to a consistent fitness burden,
since in invasive infection, the covR/S strain disseminated in
significantly greater numbers than the wild type bacteria to the
inguinal lymph node.
During preliminary experiments, we became aware that in-
dividual mice occasionally became re-infected after clearing the
initial infection. To address transmission, and the factors that may
influence this, co-mingling experiments were conducted. These
demonstrated that transmission occurred as early as 4 hours post
introduction, and the numbers of bacteria recovered from the
nares of the recipients increased as the number of infected donor
mice in the cage was increased. Importantly, such transmission
events may not necessarily constitute a productive infection, as S.
Figure 9. Density of infected carriers determines the burden of
transmitted infection. Five week old female FVB/n donor mice
infected intranasally with S. pyogenes (1.636108 cfu per dose) were
introduced into a cage of naı¨ve recipient female mice. The Donor:
Recipient (D:R) ratio was varied between 4:4, 3:5 and 2:6 between cages.
Recipient mice were sampled at 4, 24, 48, 72 and 96 hours after the
infection and introduction of the donor mice to a cage. Data show
counts from direct nasal sampling from recipient mice only. Donor mice
had .5000 cfu recovered at all time points (not shown). The burden of
transmitted infection was significantly higher in cages with a D:R ratio
of 4:4 compared with cages with a 2:4 ratio. (AUC analysis, followed by
Kruskal Wallis with Dunns Post test p,0.05). Lines indicate the median
and the interquartile range.
doi:10.1371/journal.pone.0061655.g009
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pyogenes did not reach the same abundance in recipient mice as
observed in donor mice.
Co-mingling was then used to examine the impact of covR/S on
transmission. Despite the fact that the infection burden (as
measured by direct nasal sampling) was similar between the two
donor groups in the first 72 h, recipients housed with donor mice
carrying the DcovR/S were demonstrated to have a shorter
shedding duration than the recipient mice housed with the donors
carrying the wild type strain.
Furthermore, despite some differences between the experimen-
tal groups, settle plates placed in each cage revealed no significant
difference in aerosolization between the two strains. This suggests
that the impairment of the covR/S primarily affects the survival of
S. pyogenes in the nasopharynx after the initial transmission event
has taken place.
There is thus a fitness cost conferred by covR/S mutation specific
to the nasopharynx that may explain why such bacteria have not
Figure 10. Transmission of S. pyogenes is hampered by loss of covR/S regulation. Naı¨ve five week old female FVB/n recipients co-mingled at
a D:R ratio of 3:5 with female FVB/n mice infected with either the emm75 wild type strain or it’s isogenic DcovR/S strain (56108 cfu per dose) and
sampled after the introduction of the donor mice. Donor mice had .5000 cfu recovered from direct nasal sampling throughout the experiment. The
DcovR/S strain transmitted significantly less well to recipients compared to the wild type strain (A, n = 15 recipients per group, AUC analysis, followed
by Mann-Whitney U test). Line indicates median, error bars indicate interquartile range. Settle plates exposed to the air in the cages revealed no
significant differences in the bacteria deposited on the surface of the plates by mice infected with the strain, or the DcovR/S strain (B, n = 4 plates per
cage, AUC analysis followed by Mann-Whitney U test p.0.05) Data is shown for individual animals with medians indicated by black line.
doi:10.1371/journal.pone.0061655.g010
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become prevalent in community S. pyogenes pharyngitis despite
being advantageous in invasive infection.
The model described represents a refinement of previous
systems to study upper respiratory tract infection by S. pyogenes; the
model is non-invasive and allows longitudinal monitoring of
bacterial infection, using the same mice throughout the study.
Such a model will facilitate research which might otherwise
require prohibitively large numbers of animals and could be of
importance in future evaluation of vaccines, antimicrobials, as well
as the factors that influence transmission.
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